Visual Summary: SMFM Consult Series #56: Hepatitis C in pregnancy-updated guidelines

A recent study identified key outcomes for vasa previa diagnosis and treatment, uniting patient experiences and clinical expertise to improve future research and guidelines.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

A recent study identified distinct gene signatures in placentae from gestational diabetes and pregestational diabetes pregnancies, offering potential for improved diagnosis and treatment strategies.

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

A recent study suggests that the soluble fms-like tyrosine kinase 1 to placental growth factor ratio can help predict clinical deterioration, intrapartum fetal distress, and mode of delivery, offering valuable insights for patient counseling and labor management.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.